Marathon Trading Investment Management LLC Mannkind Corp Transaction History

Marathon Trading Investment Management LLC

$149 Million
Q2 2025

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$1.14 - $2.25 $52,211 - $103,050	-45,800 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$1.02 - $2.05 $41,208 - $82,820	-40,400 Reduced 46.87%	45,800 $49,000
Q3 2018 Nov 13, 2018	SELL	$1.01 - $2.19 $7,070 - $15,330	-7,000 Reduced 7.51%	86,200 $158,000
Q2 2018 Aug 14, 2018	BUY	$1.59 - $2.38 $148,188 - $221,816	93,200 New	93,200 $177,000

Others Institutions Holding MNKD

# of Institutions

255

Shares Held

161M

Call Options Held

1.23M

Put Options Held

179K

Black Rock Inc. New York, NY

22.6M
Shares

$82.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

18.2M
Shares

$66.5 Million
0.0% of portfolio
State Street Corp Boston, MA

10.7M
Shares

$39.3 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

7.62M
Shares

$27.9 Million
0.0% of portfolio
Nitorum Capital, L.P. New York, NY

7.01M
Shares

$25.7 Million
4.77% of portfolio

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $942M
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.

Account